ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1995;60:902
© 1995 The Society of Thoracic Surgeons


Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 896.

DR DAVID J. SUGARBAKER (Boston, MA): It is interesting that you can relate the survival of patients presenting with superficial carcinoma to that of those who have been downstaged presumably from some greater stage in this particular study. Can you tell us how you determined that those patients before induction therapy were at some greater stage with or without nodal metastases, T3 invasion?

DR DOUGLAS J. MATHISEN (Boston, MA): I am curious what your surveillance program is that leads to the increased number of patients. It is an issue that all of us struggle with, and I am just curious what type of surveillance program is used at the Cleveland Clinic.

How do you identify the patients with very early lesions and decide not to pretreat them with chemotherapy or some sort of adjuvant program beforehand? Do you use ultrasound, or is it a visual identification alone? How do you decide which patients you are going to pretreat? If you think there is a very early lesion, Tis or T1, do you elect not to treat with preoperative chemotherapy and just operate?

DR F. GRIFFITH PEARSON (Toronto, Ontario): Of interest in this paper to me when I went through the abstract is the rather disappointing survival . . . [Full Text of this Article]


Related Article

Superficial Esophageal Carcinoma
Joseph F. Sabik, Thomas W. Rice, John R. Goldblum, Anuradha Koka, Thomas J. Kirby, Sharon V. Medendorp, and David J. Adelstein
Ann. Thorac. Surg. 1995 60: 896-901. [Abstract] [Full Text]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.